September 2021
First in human, modular study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced solid malignancies
Seda Author(s) P.A. Dickinson
Date: September 2021
Published: OncologyPRO
September 2021
Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR+BC)
Seda Author(s) P.A. Dickinson
Date: September 2021
Published: OncologyPRO
September 2021
Evaluation of In-situ UV Fibre Optic Arch Probe vs. traditional offline LC-UV analysis for ‘real-world’ dissolution studies
Seda Author(s) S-N. Teoh, H. Dickinson, P.A. Dickinson, C. Patterson
Date: September 2021
Published: Virtual APS PharmSci 2021
September 2021
Development of a methodology to enable non-linear in vitro-in vivo correlation for complex long-acting injections
Seda Author(s) J. Dickinson, C. Patterson, P. Gajjar, P.A. Dickinson
Date: September 2021
Published: AAPS PharmSci 360
Jan 2021
Exploring a model-based analysis of patient derived xenograft studies in oncology drug development
Seda Author(s) J. Dickinson, M. de Matas, P.A. Dickinson, H. Mistry
Date: Jan 2021
Published: PeerJ
Jan 2021
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Seda Author(s) C. Patterson
Date: Jan 2021
Published: Communications Biology
Nov 2018
Analysis of patient derived xenograft studies in Oncology drug development: impact on design and interpretation of future studies
Seda Author(s) J. Dickinson, M. de Matas, P.A. Dickinson
Date: Nov 2018
Published: PKUK, Midland Hotel, Manchester, UK
Dec 2020
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
Seda Author(s) C. Patterson
Date: Dec 2020
Published: Advanced Drug Delivery Reviews
November 2020
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report
Seda Author(s) P.A. Dickinson
Date: November 2020
Published: Journal of Pharmaceutical Sciences
Nov 2020
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies
Seda Author(s) C. Patterson, S. Budhdeo
Date: Nov 2020
Published: European Journal of Pharmaceutics and Biopharmaceutics
Jul 2020
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products
Seda Author(s) P.A. Dickinson
Date: Jul 2020
Published: The AAPS Journal
May 2020
Novel application of synchrotron x-ray computed tomography for ex-vivo imaging of subcutaneously injected polymeric microsphere suspension formulations
Seda Author(s) C. Patterson
Date: May 2020
Published: Pharmaceutical Research